PRYMFLUGO Trademark

Trademark Overview


On Monday, June 3, 2024, a trademark application was filed for PRYMFLUGO with the United States Patent and Trademark Office. The USPTO has given the PRYMFLUGO trademark a serial number of 98581155. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, January 16, 2025. This trademark is owned by GlaxoSmithKline Biologicals SA. The PRYMFLUGO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
prymflugo

General Information


Serial Number98581155
Word MarkPRYMFLUGO
Filing DateMonday, June 3, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, January 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Monday, June 3, 2024NEW APPLICATION ENTERED
Saturday, December 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 16, 2024ASSIGNED TO EXAMINER
Monday, December 23, 2024NON-FINAL ACTION E-MAILED
Monday, December 23, 2024NON-FINAL ACTION WRITTEN
Monday, December 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 8, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 8, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, January 8, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, January 8, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 9, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED